Journal of Clinical Gastroenterology and Hepatology Open Access

  • ISSN: 2575-7733
  • Journal h-index: 5
  • Journal CiteScore: 0.63
  • Journal Impact Factor: 0.41
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Market Analysis - (2019) Volume 3, Issue 2

Market Analysis - Hepatitis Congress 2020

Dr. Vinod

Assistant Professor, Hindu Rao Hospital & NDMC Medical College, India, E-mail: drvinodnikhra@gmail.com

Visit for more related articles at Journal of Clinical Gastroenterology and Hepatology

Global Hepatitis and liver diseases therapeutics market size was valued at USD 7,498.2 million in 2014. Key drivers of the market include increasing incidences of hepatocellular carcinoma and other liver diseases along with huge untapped needs of patients suffering from such diseases. Furthermore, growing global base of geriatric population is expected to enhance market demand over the forecast period.

The presence of strong pipeline and extensive R&D expenditure by pharmaceutical and biotechnology companies are the vital factors expected to propel liver diseases therapeutics market growth over the forecast period.

Liver diseases therapeutics market is experiencing growth mainly due to rapid new product lines launch. For instance, Incivek and Victrelis are the new products for the treatment of liver diseases. A strong pipeline of drugs such as GS-7977 and ThermoDox and their expected commercialization are expected to further accelerate market growth.

Rising healthcare awareness in the developing countries, strategic alliances, and partnerships between the key players of the market boost the industry growth. However, side effects and risks associated with current medication along with strict FDA and other government approval norms and availability of alternate treatment procedures act as barriers for the market.

This market is segmented on the basis of the region into North America, Europe, Asia Pacific, and Rest of World. The global market is expected to reach USD 12,095.3 million by 2022. High growth is justified by aging population in the developed economies, increasing global prevalence of liver diseases, such as hepatitis and hepatocellular carcinoma coupled with elevated demand for vaccination programs in the emerging economies, and increasing healthcare consumer expenditure in the developed economies

Major Industries associated with Gastroenterology in worldwide:

• Covidien

• EndoChoice

• Frontier Healthcare

• Sun Pharmaceutical Industries Ltd.

• Alkem Laboratories

• Boston Scientific

• FUJIFILM Medical Systems

Major Hospitals Associated with Gastroenterology in worldwide:

• Mayo Clinic

• Cleveland Clinic

• Johns Hopkins Hospital

• Massachusetts General Hospital

• Mount Sinai Hospital

• University of Chicago Medical Center

• Hospital of the University of Pennsylvania

• Ronald Reagan UCLA Medical Center

• New York-Presbyterian University Hospital of Columbia and Cornell

• Cedars-Sinai Medical Center

• UPMC-University of Pittsburgh Medical Center

• Barnes-Jewish Hospital/Washington University

• University of Michigan Hospitals and Health Centres

• Clarian Health

• Duke University Hospital

  • International Conference on Hepatitis and liver diseases

    July 13-14, 2020

    Sydney, Australia